Optimal radiotherapy dose in cervical esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy: A population based study

Author:

Li Chia‐Chin1,Chen Chih‐Yi23,Chou Ying‐Hsiang45,Huang Chih‐Jen6,Ku Hsiu‐Ying78,Chien Chun‐Ru1910ORCID

Affiliation:

1. Department of Radiation Oncology China Medical University Hsinchu Hospital Hsinchu Republic of China

2. Division of Thoracic Surgery, Department of Surgery Chung Shan Medical University Hospital Taichung Republic of China

3. Institute of Medicine, Chung Shan Medical University Taichung Republic of China

4. Department of Medical Imaging and Radiological Sciences Chung Shan Medical University Taichung Republic of China

5. Department of Radiation Oncology Chung Shan Medical University Hospital Taichung Republic of China

6. Department of Radiation Oncology Kaohsiung Medical University Hospital Kaohsiung Republic of China

7. National Institute of Cancer Research, National Health Research Institutes Miaoli Republic of China

8. Department of Healthcare Administration Asia University Taichung Republic of China

9. School of Medicine College of Medicine, China Medical University Taichung Republic of China

10. Department of Radiation Oncology China Medical University Hospital Taichung Republic of China

Funder

Health Promotion Administration, Ministry of Health and Welfare

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Reference32 articles.

1. Oesophageal cancer

2. Re: Incidence of Adenocarcinoma of the Esophagus Among White Americans by Sex, Stage, and Age

3. National Comprehensive Cancer Network Guidelines for Esophageal and Esophagogastric Junction Cancers version 5.2020 [free registration required].https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf. Accessed January 25 2021.

4. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2

5. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3